More efficient and safer
The antitumor drug was made safer for healthy tissues, increasing its effectiveness against cancer cells by an order of magnitude.
18.11.2022The antitumor drug was made safer for healthy tissues, increasing its effectiveness against cancer cells by an order of magnitude.
18.11.2022One of the patients who received DCVax after standard glioblastoma treatment is still alive seven years after the disease.
18.11.2022Siberian scientists are developing new aptamer-based test systems for the diagnosis and monitoring of Bekhterev's disease.
17.11.2022Roche antibodies targeting beta-amyloid aggregates have proven ineffective in Alzheimer's disease.
16.11.2022A vaccine developed at the University of Houston with the help of antibodies blocks the penetration of fentanyl into the brain, eliminating the euphoria reaction.
16.11.2022What discoveries has artificial intelligence made in molecular biology and how will they affect cancer treatment and life extension?
14.11.2022A new method – the introduction of the protective protein FSAP into the blood along with a tissue plasminogen activator – has been tested on mice.
14.11.2022The experimental drug causes a noticeable decrease in blood pressure in patients with hypertension resistant to conventional medications.
10.11.2022An experimental breast cancer vaccine has shown efficacy and safety in a preliminary clinical trial.
10.11.2022Russian scientists have proposed a new way to trigger apoptosis in malignant tumor cells.
08.11.2022Checking more than 301 million molecules from the virtual library revealed two promising analgesics tested so far on animals.
08.11.2022High doses of olpasiran reduced the level of lipoprotein (a) by more than 95% compared to placebo.
08.11.2022The T-cell therapeutic vaccine against HIV allowed the first volunteers to do without antiretroviral therapy for 6 months.
07.11.2022The new drug neutralizes a protein that prevents androgen blockers from binding to prostate cells.
07.11.2022Blocking of immune control points PD-1 is used in the treatment of cancer and, as it turned out, is effective in severe forms of COVID-19.
02.11.2022Targeting CAR-T cells at macrophages that protect the tumor from the immune system has slowed the development of cancer in mouse studies.
31.10.2022Impressive results have been obtained in the first phase of clinical trials of an experimental drug against liver cancer.
31.10.2022The artificial intelligence system determines COVID-19 with 99.8% accuracy even using two markers out of 11 selected from the data array.
28.10.2022Iron-containing bacteria will help to deliver targeted drugs to the tumor tissue.
28.10.2022The first drug that inhibits the MYC gene, which provokes the most common types of cancer in humans, has been successfully tested.
27.10.2022You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.